Balstilimab, CR6086, CR6086
CR6086-1-04
Phase 2 small_molecule active
Quick answer
Balstilimab, CR6086, CR6086 for Pretreated mismatch-repair-proficient and microsatellite stable metastatic colorectal cancer, and other metastatic GI cancers is a Phase 2 program (small_molecule) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharm Research Associates (UK) Limited
- Indication
- Pretreated mismatch-repair-proficient and microsatellite stable metastatic colorectal cancer, and other metastatic GI cancers
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active